Thank you, Mr. Chair. I will try to be brief.
My question is for Dr. Cohen Tervaert.
When he appeared before our committee, Mr. Boudreau from Health Canada told us that there was not enough evidence to recognize breast implant disease as the Food and Drug Administration does.
You published an article in the Expert Review of Clinical Immunology entitled "Breast implant illness: scientific evidence of its existence". I would ask you to submit it to the committee. You can share with us what you concluded in your article.
I was saying to Mr. Boudreau that when you don't have the evidence, but you have to ensure the safety of women with respect to a high-risk device, you apply the precautionary principle.
What do you think of that?